Analyst Ratings for Arcus Biosciences (RCUS)
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $49.00 (Leerink Partners)
- Lowest: $20.00 (Morgan Stanley)
- Average: $33.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.22 (+50.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$33.22 (+50.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/12/2026 | Wells Fargo | Jason Hass | Downgrade | Equal Weight (Overweight) |
23.00 (30.00) |
21.36 (22.11) |
3.51% | Details |
| 1/13/2026 | Goldman Sachs | Richard Law | New Coverage | Buy (N/A) |
28.00 (N/A) |
21.01 (22.11) |
5.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
